Published by Josh White on 26th May 2021
(Sharecast News) - Surgical endoscopy medical device company Creo Medical announced on Wednesday that data from a new paper demonstrated that the use of its 'Speedboat Inject' product was "highly likely" to be a cost-effective strategy for treating both benign and malignant large non-pedunculated colorectal polyps (LNPCP).